Literature DB >> 1167579

Malignant metastasizing angioblastic meningiomas.

E Palacios, B Azar-Kia.   

Abstract

The authors report and discuss the unusual clinical and roentgenographical features of three cases of angioblastic meningioma with extracranial metastases. The primary lesions occurred in the cervical canal, the parasagittal region, and the posterior fossa. Metastases were to lungs, liver, pancreas, and kidneys.

Entities:  

Mesh：

Year:  1975        PMID： 1167579     DOI： 10.3171/jns.1975.42.2.0185

Source DB:  PubMed          Journal:  J Neurosurg        ISSN： 0022-3085            Impact factor:   5.115


  6 in total

1.  Primary intraosseous meningioma of the mandible: CT and MR imaging features.

Authors:  M Lell; C Tudor; T Aigner; P Kessler
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

Review 2.  Extracranial metastases of meningioma.

Authors:  B Rawat; A A Franchetto; J Elavathil
Journal:  Neuroradiology       Date:  1995-01       Impact factor: 2.804

Review 3.  Hemangiopericytomatous meningioma metastasized to the liver: report of a case and review of the literature.

Authors:  T Kaneko; A Harada; K Isshiki; H Murakami; A Nakao; T Nonami; M Yano; S Kakumu; H Takagi
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

4.  Carcinomatous meningitis in a case of anaplastic meningioma.

Authors:  M Vinchon; M M Ruchoux; J P Lejeune; R Assaker; J L Christiaens
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 5.  Pancreatic metastases of cerebellar hemangiopericytoma occurring 24 years after initial presentation: report of a case.

Authors:  Takanori Hiraide; Takanori Sakaguchi; Yasushi Shibasaki; Yoshifumi Morita; Atsushi Suzuki; Keisuke Inaba; Tsutomu Tokuyama; Satoshi Baba; Shohachi Suzuki; Hiroyuki Konno
Journal:  Surg Today       Date:  2012-11-21       Impact factor: 2.549

6.  Multidetector CT of pancreatic hemangiopericytoma.

Authors:  Andrew T Trout; Khaled M Elsayes
Journal:  Cancer Imaging       Date:  2009-03-16       Impact factor: 3.909
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.